X4 Pharmaceuticals, Inc.
XFOR
$0.1908
-$0.0045-2.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.39% | -20.02% | 108.68% | -29.20% | -19.39% |
| Total Receivables | 59.37% | 25.64% | 21.65% | 24.91% | 43.00% |
| Inventory | 15.21% | 194.22% | -- | -- | -- |
| Prepaid Expenses | 24.82% | -10.05% | -13.62% | -18.25% | 27.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 0.00% |
| Total Current Assets | -21.54% | -18.50% | 100.86% | -28.46% | -17.44% |
|
|
|||||
| Total Current Assets | -21.54% | -18.50% | 100.86% | -28.46% | -17.44% |
| Net Property, Plant & Equipment | -8.51% | -6.85% | -5.43% | -6.08% | -6.31% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.85% | -1.80% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -11.98% | 32.08% | 19.91% | 3.90% | 15.43% |
| Total Assets | -17.80% | -15.41% | 87.74% | -23.82% | -15.02% |
|
|
|||||
| Total Accounts Payable | 0.51% | 7.40% | -10.62% | -0.13% | 10.02% |
| Total Accrued Expenses | 18.22% | -1.44% | 46.54% | 5.13% | -20.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.37% | 4.27% | 3.44% | 3.09% | -1.52% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.37% | 1.23% | 22.77% | 2.97% | -10.11% |
|
|
|||||
| Total Current Liabilities | 12.37% | 1.23% | 22.77% | 2.97% | -10.11% |
| Long-Term Debt | 0.27% | 0.26% | 36.86% | 0.47% | 0.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.75% | -13.28% | -12.60% | -11.26% | -8.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.54% | 20.61% | -66.51% | 89.04% | -30.23% |
| Total Liabilities | 4.85% | 2.05% | 4.51% | 15.59% | -9.03% |
|
|
|||||
| Common Stock & APIC | 0.44% | 0.34% | 0.49% | 0.33% | 0.50% |
| Retained Earnings | -8.37% | -8.36% | 17.15% | -10.83% | -4.17% |
| Treasury Stock & Other | -7.02% | 28.30% | -2.58% | -30.25% | 0.00% |
| Total Common Equity | -62.85% | -36.88% | 9,016.89% | -97.97% | -24.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -62.85% | -36.88% | 9,016.89% | -97.97% | -24.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -62.85% | -36.88% | 9,016.89% | -97.97% | -24.40% |
|
|
|||||